A ma­jor new in­vestor just ar­rived at the biotech par­ty, as Evotec nets $295M from Mubadala and No­vo

Ger­many’s Evotec has a new mi­nor­i­ty stake­hold­er, one that’s pro­vid­ing a hefty heap­ing of ini­tial cash.

Mubadala In­vest­ment Com­pa­ny, the UAE’s sov­er­eign wealth fund, has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER